Brain and Transmission Signal Modulation
Luisetto M*
Department of applied pharmacologist, Italy
Submission: April 20, 2017; Published: May 05, 201
*Corresponding author: Luisetto M, Department of applied pharmacologist, Italy, Email: Maurolu65@gmail.com
How to cite this article: György B, István P, Lajos L. Use of D-Penicillamine in the Neonatal Hyperbilirubinemias. Theranostics Brain Spine Neuro Disord. 2017; 1(1): 555553. DOI: 10.19080/TBSND.2017.01.555552
Introduction
As we can see in other discipline as cardiology a modulation in transmission of signal can reduce some aritmia. So we can think that in some pathological contidion as amygdala disfunctions (and related systems) can be Studied and observed in order to verify if modify in the neuronal transmission systems can improve this kind of disfuntions.
The so calls Side Effect of amygdala disfunctions are under our eyes every day and new diagnostic or therapeutic Instruments can be usefully introduced.
In activation of amygdala the response is more rapid than when involved the frontal cortex so we can
Think that modifying the velocity of some neuro transmission we can balance the frontal cortex activity towards amygdala [1].
The same A specific diagnostic test to evaluate the physio- pathology in neuronal transmission in this apparatus and specific pharmacological molecules can be useful tools to think to modulate this conditions if present.
Conclusion
As observed in other scientific or medical discipline controlling some non physiological cellular activity
Results in reducing of abnormal organ activation.
The same way we can think that some neuronal transmission pathway can be better pharmacologically modulate In order to have in example relevant reduction in amygdala disfuntions .
This Short Comunication has not any diagnostic or therapeutic intent, only writed in order to Produce research hipotesys.